Graft Rejection

• 

  Subject Areas on Research

  • 1990 ARRS Executive Council Award. Renal transplant rejection: diagnosis with 31P MR spectroscopy. 
  • 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. 
  • 27. Transplantation immunology: organ and bone marrow. 
  • 4D11: The Second Mouse? 
  • A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study. 
  • A Case Report of Acute Cellular Rejection Following Intestinal Transplantation Managed With Adalimumab. 
  • A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft. 
  • A case of disseminated infection with Nocardia brasiliensis in a lung transplant recipient. 
  • A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection. 
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. 
  • A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection. 
  • A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. 
  • A flow cytometric crossmatch test using endothelial precursor cells isolated from peripheral blood. 
  • A history of orthotopic heart transplantation. 
  • A human CD46 transgenic pig model system for the study of discordant xenotransplantation. 
  • A model of sequential heart and composite tissue allotransplant in rats. 
  • A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. 
  • A new rat infection-heart transplant model: effect of infection on graft survival studies. 
  • A novel approach to the treatment of chronic allograft nephropathy. 
  • A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation. 
  • A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. 
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 
  • A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor. 
  • A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. 
  • A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. 
  • A synergistic effect of total lymphoid irradiation, cyclosporine, and splenectomy in a hamster-to-rat hepatic xenograft model. 
  • Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection. 
  • Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. 
  • Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. 
  • Acute Corneal Transplant Rejection After COVID-19 Vaccination. 
  • Acute allograft rejection: cellular and humoral processes. 
  • Acute and chronic phagocyte determinants of cardiac allograft vasculopathy. 
  • Acute cellular and antibody-mediated allograft rejection. 
  • Acute cellular rejection and humoral sensitization in lung transplant recipients. 
  • Acute rejection and humoral sensitization in lung transplant recipients. 
  • Acute renal allograft rejection: difficulty in diagnosis of histologically mild cases by MR imaging. 
  • Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. 
  • Acute vascular rejection. 
  • Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model. 
  • Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. 
  • Advances in pancreas transplantation: the University of Wisconsin experience. 
  • Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. 
  • Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. 
  • Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. 
  • Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. 
  • Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells. 
  • Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. 
  • Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation. 
  • Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling. 
  • Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. 
  • Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. 
  • Allotransplantation of insulinoma into the testis of diabetic rats. 
  • Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. 
  • Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients. 
  • Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. 
  • Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. 
  • An age-independent gene signature for monitoring acute rejection in kidney transplantation. 
  • An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 
  • Analysis of cytokine dynamics in corneal allograft rejection. 
  • Analysis of failures after vascularized fibular grafting in femoral head necrosis. 
  • Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. 
  • Angiotensin II: an immune costimulator? 
  • Annual literature review for clinical transplants 2005. 
  • Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. 
  • Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. 
  • Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Anti-thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antibody desensitization therapy in highly sensitized lung transplant candidates. 
  • Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. 
  • Antibody-Mediated Rejection. 
  • Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. 
  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. 
  • Antibody-mediated rejection--an ounce of prevention is worth a pound of cure. 
  • Antigen expression in xenotransplantation: how low must it go? 
  • Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. 
  • Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. 
  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. 
  • Apoptosis and hepatic allograft reperfusion injury. 
  • Apoptotic Donor Cells in Transplantation. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. 
  • Applying the Keystone Design Perforator Island Flap Concept in a Variety of Anatomic Locations: A Review of 60 Consecutive Cases by a Single Surgeon. 
  • Arterial reconstruction for radial artery occlusion. 
  • Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity. 
  • Assessment of function, growth and development, and long-term quality of life after small bowel transplantation. 
  • Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. 
  • Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes. 
  • Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts. 
  • Association of tacrolimus time-to-therapeutic range on renal dysfunction and acute cellular rejection after orthotopic heart transplantation in a high use basiliximab population. 
  • Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients. 
  • Attitudes toward biological mesh in breast reconstruction: a regional survey of plastic surgeons. 
  • Autologous tumor rejection in humans: trimming the myths. 
  • B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen. 
  • B cells and transplantation tolerance. 
  • B cells in transplant tolerance and rejection: friends or foes? 
  • B lymphocytes differentially influence acute and chronic allograft rejection in mice. 
  • BAFF is increased in renal transplant patients following treatment with alemtuzumab. 
  • BVS5000 support after cardiac transplantation. 
  • Banff 2011 Meeting report: new concepts in antibody-mediated rejection. 
  • Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. 
  • Banff Digital Pathology Working Group: Going digital in transplant pathology. 
  • Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR). 
  • Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. 
  • Basiliximab decreases the incidence of acute rejection after intestinal transplantation. 
  • Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. 
  • Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. 
  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. 
  • Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. 
  • Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation. 
  • Biomarkers for kidney transplant rejection. 
  • Biomimetic nanoparticles for transplantation tolerance. 
  • Blazing a new TRAIL in hematopoietic cell transplantation. 
  • Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Bone marrow transplantation for sickle cell disease. 
  • Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. 
  • Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation. 
  • Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression. 
  • Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration. 
  • Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection. 
  • C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates. 
  • CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. 
  • CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. 
  • CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. 
  • CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients. 
  • CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. 
  • Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experience. 
  • Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. 
  • Campath-1H in renal transplantation: The University of Wisconsin experience. 
  • Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. 
  • Campath-1H use in pediatric renal transplantation. 
  • Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. 
  • Cardiac transplantation at Duke University Medical Center. 
  • Cardiac transplantation in a pediatric patient with systemic sclerosis. 
  • Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. 
  • Case study: heart transplantation--increased incidence of acute rejection in female recipients. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Cell-Free DNA to Detect Heart Allograft Acute Rejection. 
  • Cell-free DNA diagnostics in transplantation utilizing next generation sequencing. 
  • Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls. 
  • Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 
  • Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. 
  • Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes. 
  • Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. 
  • Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trial. 
  • Changing spectrum of pediatric renal transplantation. 
  • Characteristics of alloreactive rat T cell lines established from low and high rejecting orthotopic liver transplants. 
  • Characteristics of corneal xenograft rejection in a discordant species combination. 
  • Characterization of T cells expressing the gamma/delta antigen receptor in human renal allografts. 
  • Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2. 
  • Chemokines and their receptors in human renal allotransplantation. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Chronic kidney disease after hematopoietic cell transplantation: a systematic review. 
  • Chronic rejection of mouse kidney allografts. 
  • Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. 
  • Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction. 
  • Circulating mitochondria in organ donors promote allograft rejection. 
  • Class II alloantibody and mortality in simultaneous liver-kidney transplantation. 
  • Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. 
  • Clinical predictors and outcome implications of early readmission in lung transplant recipients. 
  • Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. 
  • Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. 
  • Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. 
  • Clinical tolerance 2008. 
  • Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. 
  • Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation. 
  • Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. 
  • Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts. 
  • Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. 
  • Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. 
  • Comparison of guided bone formation from periosteum and muscle fascia. 
  • Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). 
  • Complement system in lung transplantation. 
  • Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. 
  • Complement-mediated vasoconstriction and graft rejection. 
  • Complement-targeted therapies in kidney transplantation-insights from preclinical studies. 
  • Complications of lung transplantation: radiologic findings. 
  • Composite tissue allotransplantation: classification of clinical acute skin rejection. 
  • Composite tissue allotransplantation: classification of clinical acute skin rejection. 
  • Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. 
  • Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. 
  • Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summary. 
  • Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. 
  • Construct validity of the definition of primary graft dysfunction after lung transplantation. 
  • Contemporary Strategies and Barriers to Transplantation Tolerance. 
  • Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. 
  • Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation. 
  • Cord-blood transplants from unrelated donors in Hurler's syndrome. 
  • Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. 
  • Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study. 
  • Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. 
  • Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantation. 
  • Correlation of serologic and urinary tests with allograft biopsy in the diagnosis of pancreas rejection. 
  • Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation. 
  • Costimulation Blockade Resistant Rejection. 
  • Costimulation Blockade in Vascularized Composite Allotransplantation. 
  • Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. 
  • Costimulation blockade: towards clinical application. 
  • Critical care aspects of lung transplantation. 
  • Critical care perspective on immunotherapy in lung transplantation. 
  • Cromolyn ameliorates acute and chronic injury in a rat lung transplant model. 
  • Crosstalk Between T and B Cells in the Germinal Center After Transplantation. 
  • Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantation. 
  • Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. 
  • Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination. 
  • Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation. 
  • Current concepts and controversies in lung transplantation. 
  • Current indications for hand and face allotransplantation. 
  • Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. 
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection. 
  • Cytokine kinetics profiling in pediatric renal transplant recipients. 
  • Cytomegalovirus keratitis after penetrating keratoplasty. 
  • Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. 
  • DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. 
  • Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. 
  • De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years. 
  • De novo belatacept in clinical vascularized composite allotransplantation. 
  • Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. 
  • Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 
  • Defining long-term outcomes with living donor liver transplantation in North America. 
  • Definition and Analysis of Textbook Outcome: A Novel Quality Measure in Kidney Transplantation. 
  • Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience. 
  • Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion. 
  • Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation. 
  • Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway. 
  • Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients. 
  • Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant. 
  • Desensitization and management of allograft rejection. 
  • Design and Implementation of the International Genetics and Translational Research in Transplantation Network. 
  • Detection of renal allograft rejection by computer 
  • Development and future deployment of a 5 years allograft survival model for kidney transplantation. 
  • Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. 
  • Diagnosis and outcome of early pleural space infection following lung transplantation. 
  • Diagnostic tools for monitoring kidney transplant recipients. 
  • Diagnostic yield of bronchoscopies after isolated lung transplantation. 
  • Diarrhea in a Patient With Combined Kidney-Pancreas Transplant. 
  • Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. 
  • Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. 
  • Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice. 
  • Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model. 
  • Differential regulation of leucocyte L-selectin (CD62L) expression in normal lymphoid and inflamed extralymphoid tissues. 
  • Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. 
  • Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. 
  • Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation. 
  • Discordant complement systems as a factor in hyperacute xenograft rejection. 
  • Dislocation of the donor graft to the posterior segment in descemet stripping automated endothelial keratoplasty. 
  • Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing. 
  • Do macrophages destroy nascent tumors? 
  • Does recipient age impact functional outcomes of orthotopic heart transplantation? 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Donor Allospecific CD44high Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease. 
  • Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. 
  • Donor apoptotic cell-based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients. 
  • Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. 
  • Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. 
  • Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts. 
  • Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial. 
  • Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients. 
  • Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. 
  • Early Immune Response to Acute Gastric Fluid Aspiration in a Rat Model of Lung Transplantation. 
  • Early Postoperative Complications following Gracilis Free Muscle Transfer for Facial Reanimation: A Systematic Review and Pooled Data Analysis. 
  • Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. 
  • Early barriers to neonatal porcine islet engraftment in a dual transplant model. 
  • Editorial: Sensitization and Desensitization in Organ Transplantation. 
  • Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. 
  • Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. 
  • Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction. 
  • Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction. 
  • Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. 
  • Effect of cyclosporin pharmacokinetics on renal allograft outcome in African-Americans. 
  • Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts. 
  • Effect of donor factors on early graft survival in adult cadaveric renal transplantation. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection. 
  • Effect of surrogate tolerogenesis on the vascular rejection of pig heart xenografts. 
  • Effector mechanisms in transplant rejection. 
  • Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk. 
  • Effects of Immunosuppressive Medications on Mitochondrial Function. 
  • Effects of Sofosbuvir-Based Hepatitis C Treatment Regimens on Calcineurin Inhibitor Dosing in Liver and Kidney Transplant Recipients. 
  • Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. 
  • Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management. 
  • Efficacy and safety of mammalian target of rapamycin inhibitors following intestinal and multivisceral transplantation. 
  • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. 
  • Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. 
  • Efficacy of signal-averaged electrocardiography in the young orthotopic heart transplant patient to detect allograft rejection. 
  • Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. 
  • Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. 
  • Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. 
  • Endothelial cell antibodies associated with novel targets and increased rejection. 
  • Endothelial graft failure after contralateral autologous corneal transplantation. 
  • Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques. 
  • Eosinophils in corneas removed by penetrating keratoplasty. 
  • Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation. 
  • Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. 
  • Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. 
  • Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. 
  • Evaluation of Weight-Based Dose During Transition From Immediate-Release to Extended-Release Tacrolimus in Kidney Transplant Recipients. 
  • Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. 
  • Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. 
  • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. 
  • Evidence for an immune barrier after in utero hematopoietic-cell transplantation. 
  • Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. 
  • Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation? 
  • Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. 
  • Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. 
  • Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. 
  • Exfoliative cytopathologic studies in organ transplantation IV. The cytologic diagnosis of herpesvirus in the urine of renal allograft recipients. 
  • Exfoliative cytopathologic studies in organ transplantation. V. The diagnosis of rejection in the immediate postoperative period. 
  • Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. 
  • Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. 
  • Experience with protocol biopsies after solitary pancreas transplantation. 
  • Experience with protocol biopsies after solitary pancreas transplantation. 
  • Experimental modeling of desensitization: What have we learned about preventing AMR? 
  • Expression microarray identifies novel markers of free flap failure in a rat model. 
  • Expression of heme oxygenase-1 can determine cardiac xenograft survival. 
  • FK 506 induction and rescue therapy in pancreas transplant recipients. 
  • FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. 
  • Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. 
  • Fate of four cadaveric donor renal allografts with mesangial IgA deposits. 
  • Finding the right job for the tool: alemtuzumab and its role in renal transplantation. 
  • Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. 
  • Free jejunal interposition graft for reconstruction of the esophagus. 
  • Functional Characteristics and Phenotypic Plasticity of CD57+PD1- CD4 T Cells and Their Relationship with Transplant Immunosuppression. 
  • Functional role of thromboxane production by acutely rejecting renal allografts in rats. 
  • Functionally significant renal allograft rejection is defined by transcriptional criteria. 
  • Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. 
  • Gamma-irradiation reduces the allogenicity of donor corneas. 
  • Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. 
  • Gastroesophageal reflux and altered motility in lung transplant rejection. 
  • Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction. 
  • Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation. 
  • Gene targeting: applications in transplantation research. 
  • Genetic determinants of renal transplant outcome: where do we stand? 
  • Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. 
  • Genetic therapies for xenotransplantation. 
  • Glutathione depletion in epithelial lining fluid of lung allograft patients. 
  • Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. 
  • Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. 
  • Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. 
  • H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection. 
  • HCV Positive Allograft Use in Heart Transplant: A Silver Lining to an Epidemic. 
  • HL A typing, mixed leukocyte reactivity, and skin graft survival in a family with a recombinant at the HL-1 chromosomal region (major transplantation region). 
  • HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation. 
  • Hand transplantation in the United States: experience with 3 patients. 
  • Hand transplantation. 
  • Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions. 
  • Heart transplantation in neonates and in children. 
  • Heart xenograft survival with chimeric pig donors and modest immune suppression. 
  • Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. 
  • Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction. 
  • Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. 
  • Hepatic allograft-derived Kupffer cells regulate T cell response in rats. 
  • Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. 
  • Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation. 
  • Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. 
  • Hepatitis E virus infection and rejection in kidney transplant recipients. 
  • Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection. 
  • High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. 
  • High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade. 
  • Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant. 
  • Histocompatibility and liver transplantation. 
  • Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies. 
  • Histopathologic examination of failed grafts in descemet's stripping with automated endothelial keratoplasty. 
  • Histopathologic features of rejecting orthotopic corneal xenografts. 
  • Hitting the reset button for immune tolerance. 
  • Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes. 
  • Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. 
  • Human antiporcine mixed lymphocyte reaction. 
  • Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. 
  • Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. 
  • Humoral rejection of rat hepatic transplants by passive transfer of serum. 
  • Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. 
  • Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. 
  • Hyperacute rejection of liver transplants in rats. 
  • Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice. 
  • Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation. 
  • Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. 
  • IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. 
  • IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. 
  • IL-15 expanded CD8+CD122+ cells: when do they suppress? 
  • IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation Blockade. 
  • IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection. 
  • ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements. 
  • ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. 
  • IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients. 
  • Ileocolonic perforation. A complication following renal transplantation. 
  • Immune cells in a mouse airway model of obliterative bronchiolitis. 
  • Immune competence of germ-free rats. I. Increased responsiveness to transplantation and other antigens. 
  • Immune mechanisms of lung allograft rejection. 
  • Immune profiling: molecular monitoring in renal transplantation. 
  • Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. 
  • Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. 
  • Immunologic barriers to xenotransplantation. 
  • Immunologic considerations in composite tissue transplantation: overview. 
  • Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells. 
  • Immunologic mechanisms of transplant rejection. 
  • Immunologic risks of combined kidney-pancreas transplantation. 
  • Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection. 
  • Immunological studies on eluates from human renal allografts. 
  • Immunology of transplantation in the central nervous system. 
  • Immunoregulation and tolerance. 
  • Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world. 
  • Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. 
  • Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. 
  • Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. 
  • Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. 
  • Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation. 
  • Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. 
  • Impact of infection on transplantation tolerance. 
  • Impact of psychosocial factors on medication level variability index and outcomes in pediatric liver transplant recipients. 
  • Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. 
  • Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. 
  • Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation. 
  • Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. 
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection. 
  • In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts. 
  • In vitro and in vivo human T cell repertoire in kidney allograft rejection. 
  • In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane. 
  • Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population. 
  • Incidence of acute cellular rejection following granulocyte colony-stimulating factor administration in lung transplantation: A retrospective case-cohort analysis. 
  • Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients. 
  • Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. 
  • Increased Calculated Panel Reactive Antigen and Symbiosis: The Art of Living and Surviving Together. 
  • Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD). 
  • Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts. 
  • Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? 
  • Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model. 
  • Indications and techniques for renal, pancreas, and liver transplantation. 
  • Indications for and outcomes of repeat penetrating keratoplasty, 1989-1995. 
  • Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. 
  • Induction immunosuppression in liver transplantation: a review. 
  • Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. 
  • Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. 
  • Infant pediatric liver transplantation results equal those for older pediatric patients. 
  • Infection prophylaxis in pancreas transplant recipients. 
  • Infections after kidney transplantation. Does age matter? 
  • Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study. 
  • Infections in patients with cystic fibrosis following lung transplantation. 
  • Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. 
  • Influence of gender on allograft rejection in a rat heart transplant model. 
  • Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant. 
  • Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. 
  • Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. 
  • Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. 
  • Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial. 
  • Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. 
  • Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primates. 
  • Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. 
  • Initial experience using rapamycin immunosuppression in pediatric intestinal transplant recipients. 
  • Innate Functions of Dendritic Cell Subsets in Cardiac Allograft Tolerance. 
  • Innate immunity influences long-term outcomes after human lung transplant. 
  • Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient. 
  • Insurance and education predict long-term survival after orthotopic heart transplantation in the United States. 
  • Interleukin-15 receptor blockade in non-human primate kidney transplantation. 
  • Intestinal transplantation: the University of Wisconsin experience. 
  • Intestine Transplantation Across a Positive Crossmatch With Preformed Donor-Specific Antibodies. 
  • Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. 
  • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. 
  • Invited commentary. 
  • In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection. 
  • Is Functional Independence Associated With Improved Long-Term Survival After Lung Transplantation? 
  • Is there a transfusion effect in combined pancreas-kidney transplantation? 
  • Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? 
  • Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. 
  • Isolated intestinal transplantation for intestinal failure. 
  • J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. 
  • Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up. 
  • Kinetics of hepatitis C virus reinfection after liver transplantation. 
  • Knee osteotomy and meniscal transplantation: indications, technical considerations, and results. 
  • Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. 
  • Laparoscopic antireflux surgery in the lung transplant population. 
  • Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. 
  • Laryngeal transplantation and 40-month follow-up. 
  • Late coexistent acute cellular and antibody-mediated rejection in non-sensitized renal transplant patients. 
  • Late first acute rejection in pediatric kidney transplantation: A North American Pediatric Renal Trials and Collaborative Studies special study. 
  • Late graft loss and long-term outcome after isolated intestinal transplantation in children. 
  • Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. 
  • Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. 
  • Late withdrawal of cyclosporine in stable renal transplant recipients. 
  • Less Is More in Post Pediatric Heart Transplant Care. 
  • Less is more: maintenance minimization as a step toward tolerance. 
  • Letter to the editor in response to: Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life sustaining NHP renal allo- and xeno-transplants by Firl and Markmann. 
  • Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. 
  • Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. 
  • Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. 
  • Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence. 
  • Liver transplant biopsies with a biopsy gun. 
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. 
  • Liver transplantation from controlled non-heart-beating donors. 
  • Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. 
  • Liver transplantation. 
  • Living unrelated kidney donation: an underutilized resource? 
  • Living unrelated renal donation: the University of Wisconsin experience. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Location, location, location: regional immune mechanisms critically influence rejection. 
  • Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. 
  • Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. 
  • Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. 
  • Long-term management of the liver transplant patient: recommendations for the primary care doctor. 
  • Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. 
  • Long-term outcomes and management of the heart transplant recipient. 
  • Long-term outcomes and quality of life after intestine transplantation. 
  • Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. 
  • Long-term pancreatic function: potential benefits. 
  • Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. 
  • Long-term results of liver transplantation for biliary atresia. 
  • Long-term results of liver transplantation in older patients 60 years of age and older. 
  • Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. 
  • Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. 
  • Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin. 
  • Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. 
  • Lung Retransplantation. 
  • Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. 
  • Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. 
  • Lung Transplantation and the Era of the Sensitized Patient. 
  • Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation at Duke University. 
  • Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients. 
  • Lung-resident mesenchymal stromal cells. A new player in post-transplant bronchiolitis obliterans syndrome? 
  • Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients. 
  • Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. 
  • Lymphodepletional strategies in transplantation. 
  • MR imaging of renal transplants. 
  • Machine perfusion of donor kidneys may reduce graft rejection. 
  • Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. 
  • Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Marrow transplant experience for children with severe aplastic anemia. 
  • Marrow transplantation for aplastic anemia. 
  • Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. 
  • Marrow transplantation for severe aplastic anemia and thalassemia major. 
  • Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. 
  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? 
  • Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. 
  • Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. 
  • Mediation of hyperacute rejection of rat hepatic allografts by RT-1 antigens. 
  • Medication Nonadherence After Lung Transplantation in Adult Recipients. 
  • Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation. 
  • Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. 
  • Memory T cells in organ transplantation: progress and challenges. 
  • Memory T-cell-specific therapeutics in organ transplantation. 
  • Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. 
  • Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer. 
  • Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. 
  • Molecular barriers to xenotransplantation. 
  • Molecular evaluation of BK polyomavirus nephropathy. 
  • Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. 
  • Monocyte infiltration and kidney allograft dysfunction during acute rejection. 
  • Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients. 
  • Myocardial acoustics in pediatric allograft rejection. 
  • Nanoparticle Platforms for Antigen-Specific Immune Tolerance. 
  • Natural killer cell-endothelial cell interactions in xenotransplantation. 
  • Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients. 
  • New developments in the diagnosis and treatment of infections in lung transplant recipients. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • Newborn baboon immunity: lessons in cross-species transplantation. 
  • Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. 
  • Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. 
  • Non-human to human organ transplantation: its biologic basis and a potential role for radiation therapy. 
  • Nonadherence is associated with late rejection in pediatric heart transplant recipients. 
  • Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. 
  • Novel Magnetic Resonance Imaging for Assessment of Bronchial Stenosis in Lung Transplant Recipients. 
  • Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. 
  • OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. 
  • Of ends and means. 
  • Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. 
  • One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. 
  • Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate. 
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. 
  • Oral beclomethasone therapy for recurrent small bowel allograft rejection and intestinal graft-versus-host disease. 
  • Orotic acid improves left ventricular recovery four days after heterotopic transplantation. 
  • Orthotopic liver transplantation in patients 60 years of age and older. 
  • Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. 
  • Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. 
  • Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. 
  • Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system. 
  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. 
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. 
  • Overcoming Chronic Rejection-Can it B? 
  • Pancreas Transplantation: Indications, Techniques, and Outcomes. 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation: the Nebraska experience. 
  • Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. 
  • Parathyroid autotransplantation: use of cryopreserved glands in an investigation of hypocalcemia. 
  • Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. 
  • Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. 
  • Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. 
  • Peptic ulcer disease following renal transplantation. 
  • Perineal and lower extremity reconstruction. 
  • Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. 
  • Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord. 
  • Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. 
  • Pharmaceutical expenses after kidney and kidney-pancreas transplantation. 
  • Pharmacological approaches to antibody-mediated rejection-Are we getting closer? 
  • Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts. 
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts. 
  • Phenotype of infiltrating cells in an ex vivo model of human antiporcine hyperacute cardiac xenograft rejection. 
  • Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation. 
  • Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. 
  • Physical Crossmatching vs Virtual Crossmatching: The end of an era? or Why give up a good thing? 
  • Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction. 
  • Plasma cells and acute rejection of a near-total face transplant: an incidental finding or an evolving plasma-cell-mediated rejection? 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. 
  • Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. 
  • Platelets influence vascularized organ transplants from start to finish. 
  • Pneumocystis carinii pneumonia in renal transplant recipients. 
  • Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates. 
  • Possible production of immunosuppression in the host by exposure to microorganisms: observations in germfree rats. 
  • Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. 
  • Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). 
  • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. 
  • Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 
  • Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses within Failing Prosthetic Arteriovenous Grafts. 
  • Postoperative cognitive dysfunction and mortality following lung transplantation. 
  • Postoperative management of heart transplantation patients. 
  • Potential of costimulation-based therapies for composite tissue allotransplantation. 
  • Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry. 
  • Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? 
  • Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. 
  • Prediction of corneal graft rejection using central endothelium/Descemet's membrane complex thickness in high-risk corneal transplants. 
  • Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study. 
  • Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. 
  • Pregnancy in a patient with Goodpasture syndrome and renal transplantation. 
  • Pregnancy in transplant recipients. 
  • Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. 
  • Preliminary experience with FK 506 in pancreas transplant recipients. 
  • Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model. 
  • Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. 
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. 
  • Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. 
  • Prevention of autoimmune islet allograft destruction by engraftment of donor T cells. 
  • Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. 
  • Prevention trumps treatment of antibody-mediated transplant rejection. 
  • Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. 
  • Primate skin allotransplantation with anti-CD154 monotherapy. 
  • Proceedings: Immunologic similarities between fetal cell antigens and tumor cell antigens in guinea pigs. 
  • Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. 
  • Prolonged discordant cardiac xenograft survival in newborn recipients. 
  • Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. 
  • Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine. 
  • Prolonged survival of class II transactivator-deficient cardiac allografts. 
  • Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. 
  • Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. 
  • Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. 
  • Psychosocial Predictors of Mortality Following Lung Transplantation. 
  • Quantifying renal allograft loss following early antibody-mediated rejection. 
  • Quantifying the risk of incompatible kidney transplantation: a multicenter study. 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Quantitative cardiac magnetic resonance T2 imaging offers ability to non-invasively predict acute allograft rejection in children. 
  • Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. 
  • Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. 
  • Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. 
  • Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction. 
  • Radiation therapy for renal transplant rejection refractory to pulse steroids and OKT3. 
  • Rank tests for clustered survival data when dependent subunits are randomized. 
  • Rank tests for matched survival data. 
  • Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig. 
  • Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. 
  • Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. 
  • Recent History of Serious Fall Injuries and Posttransplant Outcomes Among US Kidney Transplant Recipients. 
  • Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. 
  • Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance. 
  • Recipient Kupffer cell influx into xenografted liver. 
  • Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. 
  • Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy. 
  • Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. 
  • Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. 
  • Reflux and allograft dysfunction: is there a connection? 
  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials. 
  • Rejection in the setting of non-HLA antibody: New tools for navigating bench to bedside. 
  • Rejection of kidney allografts by MHC class I-deficient mice. 
  • Rejection of the liver transplant. 
  • Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells. 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation. 
  • Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation. 
  • Relationships among renal allograft biopsy infiltrates, growth of T cell lines, and irreversible rejection. 
  • Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. 
  • Renal allograft cell infiltrates associated with irreversible rejection. 
  • Renal allograft rejection: evaluation by Doppler US and MR imaging. 
  • Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. 
  • Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. 
  • Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. 
  • Renal transplantation at the University of Wisconsin in the cyclosporine era. 
  • Renal transplantation between HL-A haploidentical donor-recipient pairs: functional and morphological evaluation. 
  • Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. 
  • Renal transplantation between histocompatible donor-recipient pairs. 
  • Renal transplantation in children. 
  • Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. 
  • Report from a consensus conference on antibody-mediated rejection in heart transplantation. 
  • Report from a consensus conference on primary graft dysfunction after cardiac transplantation. 
  • Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations. 
  • Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. 
  • Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. 
  • Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection". 
  • Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. 
  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). 
  • Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. 
  • Results of free vascularized fibular grafting for femoral head osteonecrosis in patients with systemic lupus erythematosus. 
  • Results of penetrating keratoplasty associated with silicone oil retinal tamponade. 
  • Results of penetrating keratoplasty by residents. 
  • Results of solitary pancreas transplantation with enteric drainage: is there a benefit from monitoring urinary amylase levels? 
  • Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. 
  • Rethinking the ross procedure in adults. 
  • Retransplantation in the diabetic patient with a pancreas allograft. 
  • Reversal of acute allograft rejection using immunotoxin. 
  • Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. 
  • Revisiting a single day salvage conditioning following graft failure. 
  • Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells. 
  • Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study. 
  • Risk factors for BK polyomavirus nephritis in renal allograft recipients. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. 
  • Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection. 
  • Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection. 
  • Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation. 
  • Role of complement activation in obliterative bronchiolitis post-lung transplantation. 
  • Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. 
  • Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. 
  • Role of low-dose calcineurin inhibitor regimens in pediatric kidney transplantation. 
  • Role of platelet activating factor in kidney transplant rejection in the rat. 
  • SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? 
  • Safety and feasibility of renal blood flow determination during kidney transplant surgery with perfusion ultrasonography. 
  • Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Science of composite tissue allotransplantation. 
  • Second marrow infusion for poor graft function after allogeneic marrow transplantation. 
  • Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. 
  • Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study. 
  • Seek and you will find: antibody and the liver. 
  • Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model. 
  • Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. 
  • Sensitization and Desensitization in Vascularized Composite Allotransplantation. 
  • Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. 
  • Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox. 
  • Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. 
  • Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation. 
  • Significance of and risk factors for the development of central airway stenosis after lung transplantation. 
  • Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. 
  • Significance of cytokine gene polymorphism in renal transplantation. 
  • Significance of the Banff borderline biopsy. 
  • Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers. 
  • Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection. 
  • Similarities in long-term alloreactive T cell lines propagated from transfusion-enhanced and control-rejecting rat renal allografts. 
  • Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). 
  • Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? 
  • Simultaneous pancreas-kidney transplantation at the University of Wisconsin. 
  • Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. 
  • Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection. 
  • Single-center analysis of infectious complications in older adults during the first year after kidney transplantation. 
  • Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. 
  • Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. 
  • Skin graft rejection between subjects genotyped for HL-A. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Solitary pancreas allografts. The role of percutaneous biopsy and standardized histologic grading of rejection. 
  • Solitary pancreas transplantation: experience with 50 consecutive cases. 
  • Spectrum of humoral rejection after pediatric heart transplantation. 
  • Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. 
  • Starting well: induction immunosuppression after organ transplantation. 
  • Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials. 
  • Stool calprotectin monitoring after small intestine transplantation. 
  • Strategies for minimizing immunosuppression in kidney transplantation. 
  • Structure and specific antigens of avian leukosis viruses. 
  • Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Suction cup/contact lens complications following penetrating keratoplasty. 
  • Sudden cardiac death after heart transplantation: can ICD prevent SCD? 
  • Summary of FDA antibody-mediated rejection workshop. 
  • Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. 
  • Surgical considerations in lung transplantation: transplant operation and early postoperative management. 
  • Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. 
  • Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts. 
  • Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. 
  • Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. 
  • Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. 
  • Survival after bronchiolitis obliterans syndrome. 
  • System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. 
  • Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. 
  • Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 
  • Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. 
  • Tailored use of belatacept in adolescent kidney transplantation. 
  • Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation. 
  • Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. 
  • Th17 cell inhibition in a costimulation blockade-based regimen for vascularized composite allotransplantation using a nonhuman primate model. 
  • The Banff 2007 working classification of skin-containing composite tissue allograft pathology. 
  • The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation. 
  • The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. 
  • The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. 
  • The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. 
  • The STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. 
  • The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients. 
  • The azaspirane SKF 105685 ameliorates renal allograft rejection in rats. 
  • The cam-path forward. 
  • The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. 
  • The clinical application of monoclonal antibody therapies in renal transplantation. 
  • The clinical relevance of alloantibody in liver transplantation. 
  • The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. 
  • The cornea has "the nerve" to encourage immune rejection. 
  • The desirable donor pig to eliminate all xenoreactive antigens. 
  • The effect of soluble complement receptor type 1 on hyperacute allograft rejection. 
  • The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. 
  • The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. 
  • The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury. 
  • The effects of surgery and acute rejection on glomerular hemodynamics in the transplanted rat kidney. 
  • The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. 
  • The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection? 
  • The future promises of xenotransplantation. 
  • The heart is just a muscle. 
  • The immunogenetics of the major histocompatibility chromosomal region in man. 
  • The immunologic constant of rejection. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The impact of post-transplant diabetes mellitus on liver transplant outcomes. 
  • The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients. 
  • The importance of class I and class II HLA in cadaveric renal transplantation. 
  • The influence of RS-61443 on antibody-mediated rejection. 
  • The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. 
  • The interleukin-2 receptor α chain (CD25) plays an important role in regulating monocyte-derived CD40 expression during anti-porcine cellular responses. 
  • The intragraft CD8+ T cell response in renal allograft rejection in the mouse. 
  • The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The outstanding questions in transplantation: It's about time…. 
  • The past, present, and future of costimulation blockade in organ transplantation. 
  • The problem of transplanting the sensitized patient: whose problem is it? 
  • The rehabilitation of renal allograft recipients. 
  • The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. 
  • The role of B cells in solid organ transplantation. 
  • The role of CD154 in organ transplant rejection and acceptance. 
  • The role of MR imaging in the assessment of renal allograft vasculature. 
  • The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. 
  • The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation. 
  • The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. 
  • The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. 
  • The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. 
  • The role of bronchoscopy in the management of lung transplant recipients. 
  • The role of class I antigens in hyperacute rejection of hepatic allografts in rats. 
  • The role of donor-specific HLA alloantibodies in liver transplantation. 
  • The role of human CD46 in early xenoislet engraftment in a dual transplant model. 
  • The role of innate immunity in acute allograft rejection after lung transplantation. 
  • The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. 
  • The role of non-HLA antibodies in solid organ transplantation: a complex deliberation. 
  • The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends. 
  • The significance of pre-operative coronary interventions on outcome after pancreas transplantation. 
  • The use of local allograft irradiation following renal transplantation. 
  • The utility of retroperitoneal kidney placement in simultaneous kidney pancreas transplantation. 
  • Therapeutic angiography in renal transplant complications. 
  • Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine. 
  • Therapeutic strategies for xenograft rejection. 
  • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. 
  • Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. 
  • Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. 
  • Tolerance and the "Holy Grail" of transplantation. 
  • Toll-like receptors and allograft rejection. 
  • Toll-like receptors, innate immunity and lung transplantation. 
  • Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates. 
  • Total respiratory support from swine lungs in primate recipients. 
  • Transcutaneous PO2 monitoring for assessing viability and predicting survival of skin flaps: experimental and clinical correlations. 
  • Transplantation immunology: solid organ and bone marrow. 
  • Transplantation in miniature swine. III: effects of MSLA and A-O blood group matching on skin allograft survival. 
  • Transplantation in miniature swine. VI. Factors influencing survival of renal allografts. 
  • Transplantation of discordant xenografts: a challenge revisited. 
  • Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Transplantation of rat insulinoma allografts with cyclosporin A. 
  • Transplantation of the entire small bowel in inbred rats using cyclosporine. 
  • Transplanting the highly sensitized patient: trials and tribulations. 
  • Transplants for non-lethal conditions: a case against hand transplantation in minors. 
  • Treatment of intestinal failure: intestinal transplantation. 
  • Treatment of osteonecrosis in the hip of pediatric patients by free vascularized fibular graft. 
  • Treatment of refractory acute rejection in a lung transplant recipient with campath 1H. 
  • Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. 
  • Treatment with immunotoxin. 
  • Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. 
  • Tumor necrosis factor-α pathway plays a critical role in regulating interferon-γ induced protein-10 production in initial allogeneic human monocyte-endothelial cell interactions. 
  • Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. 
  • Umbilical cord blood transplantation for non-malignant diseases. 
  • Undernutrition and Hypoleptinemia Modulate Alloimmunity and CMV-specific Viral Immunity in Transplantation. 
  • Unique aspects of rejection and tolerance in liver transplantation. 
  • Unique immunologic problems in human bone marrow transplant recipients. 
  • Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 
  • Update in lung transplantation 2013. 
  • Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. 
  • Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. 
  • Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. 
  • Urine proteomics in kidney transplantation. 
  • Urologic morbidity in renal transplantation. 
  • Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. 
  • Use of OKT3 in kidney, pancreas, and liver transplantation. 
  • Use of allograft biopsies to assess thymopoiesis after thymus transplantation. 
  • Use of donor serum to prevent passive transfer of hyperacute rejection. 
  • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. 
  • Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection. 
  • Usefulness of left ventricular inflow Doppler in predicting rejection in pediatric cardiac transplant recipients. 
  • Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. 
  • Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. 
  • Utilizing Indocyanine Green Dye Angiography to Detect Simulated Flap Venous Congestion in a Novel Experimental Rat Model. 
  • Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. 
  • Variables affecting the T cell receptor V beta repertoire heterogeneity of T cells infiltrating human renal allografts. 
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. 
  • Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice. 
  • Vascularized composite allotransplantation at a crossroad. 
  • Vascularized composite allotransplantation: a closer look at the banff working classification. 
  • Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study. 
  • Viral-induced CD28 loss evokes costimulation independent alloimmunity. 
  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society. 
  • What's new in childhood organ transplantation. 
  • Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. 
  • Xanthogranulomatous pyelonephritis in renal transplant recipient. 
  • Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine. 
  • Youngest Composite Full-Face Transplant: A Model for Vascularized Composite Allograft in Younger Populations. 
• 

  Keywords of People

  • Alexander, Barbara Dudley, Professor of Medicine, Pathology
  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Gunn, Michael Dee, Professor of Medicine, Integrative Immunobiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Palmer Jr., Scott Michael, Donald F. Fortin, M.D. Distinguished Professor of Medicine, Duke Innovation & Entrepreneurship